Correction: Mol Med (2021) 27:14 https://doi.org/10.1186/s10020-021-00271-w
Following publication of the original article (Chen et al. 2021), the authors informed us that there are some mistakes in the manuscript due to their carelessness. The image of H/R group in Fig. 2E and the image of H/R + 3-MA group in Fig. 4G was repeated.
Reference
Chen H-Y, Xiao Z-Z, Ling X, Xu R-N, Zhu P, Zheng S-Y. ELAVL1 is transcriptionally activated by FOXC1 and promotes ferroptosis in myocardial ischemia/reperfusion injury by regulating autophagy. Molecular Medicine. 2021;27:14. https://doi.org/10.1186/s10020-021-00271-w.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Chen, HY., Xiao, ZZ., Ling, X. et al. Correction: ELAVL1 is transcriptionally activated by FOXC1 and promotes ferroptosis in myocardial ischemia/reperfusion injury by regulating autophagy. Mol Med 28, 96 (2022). https://doi.org/10.1186/s10020-022-00529-x
Published:
DOI: https://doi.org/10.1186/s10020-022-00529-x